Nasal high flow does not improve exercise tolerance in COPD patients recovering from acute exacerbation: A randomized crossover study
- PMID: 31387158
- DOI: 10.1111/resp.13664
Nasal high flow does not improve exercise tolerance in COPD patients recovering from acute exacerbation: A randomized crossover study
Abstract
Background and objective: We hypothesized that by reducing respiratory work and improving gas exchange, nasal high flow (NHF) would improve exercise tolerance in patients with chronic obstructive pulmonary disease (COPD) following respiratory exacerbation.
Methods: This was a monocentric, randomized, controlled crossover study. Patients with severe to very severe COPD carried out two high-intensity constant work-rate exercise tests (CWRET) with and without NHF on two consecutive days. The primary outcome was the mean difference in endurance time between both conditions. The secondary aims included vastus lateralis oxygenation (StO2 ), dyspnoea, leg discomfort, maximal inspiratory pressure (MIP), transcutaneous CO2 pressure (PtcCO2 ), respiratory rate (RR), heart rate (HR) and pulsed O2 saturation (SpO2 ), as well as the patients' opinions of the device.
Results: A total of 19 patients were included (mean forced expiratory volume in 1 s = 28.7 ± 10.8%, age = 62.1 ± 9.1 years). No significant differences in endurance time during the CWRET were found between the two test conditions (-66.58 (95% CI: -155.9 to 22.7) s, P = 0.12). StO2 , PtCO2 and HR were reduced at the end of the exercise with NHF (-2.1% (95% CI: -4.3 to -0.0); -1.3 mm Hg (95% CI: -2.5 to -0.2); -2.7 bpm (95% CI: -5.0 to -0.5), respectively, P ≤ 0.05). No significant differences were found for any of the other secondary outcomes. Half of the patients evaluated the device as being moderately to very uncomfortable.
Conclusion: NHF during exercise did not increase endurance time in patients with COPD following exacerbation.
Clinical trial registration: NCT03058081 at clinicaltrials.gov.
Keywords: chronic obstructive pulmonary disease; exercise; muscle oxygenation; nasal high flow; pulmonary rehabilitation.
© 2019 Asian Pacific Society of Respirology.
Comment in
-
Nasal high-flow therapy: Established roles and emerging opportunities.Respirology. 2019 Nov;24(11):1039-1041. doi: 10.1111/resp.13677. Epub 2019 Sep 5. Respirology. 2019. PMID: 31486584 No abstract available.
References
REFERENCES
-
- Anzueto A. Impact of exacerbations on COPD. Eur. Respir. Rev. 2010; 19: 113-8.
-
- Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet 2007; 370: 786-96.
-
- Harrison SL, Robertson N, Graham CD, Williams J, Steiner MC, Morgan MDL, Singh SJ. Can we identify patients with different illness schema following an acute exacerbation of COPD: a cluster analysis. Respir. Med. 2014; 108: 319-28.
-
- Benzo R, Wetzstein M, Neuenfeldt P, McEvoy C. Implementation of physical activity programs after COPD hospitalizations: lessons from a randomized study. Chron. Respir. Dis. 2015; 12: 5-10.
-
- van 't Hul A. Training with inspiratory pressure support in patients with severe COPD. Eur. Respir. J. 2006; 27: 65-72.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical